These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 7535092)

  • 1. Expression of the Wilms' tumor gene WT1 in human malignant mesothelioma cell lines and relationship to platelet-derived growth factor A and insulin-like growth factor 2 expression.
    Langerak AW; Williamson KA; Miyagawa K; Hagemeijer A; Versnel MA; Hastie ND
    Genes Chromosomes Cancer; 1995 Feb; 12(2):87-96. PubMed ID: 7535092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Wilms' tumor 1 susceptibility (WT1) gene products are selectively expressed in malignant mesothelioma.
    Amin KM; Litzky LA; Smythe WR; Mooney AM; Morris JM; Mews DJ; Pass HI; Kari C; Rodeck U; Rauscher FJ
    Am J Pathol; 1995 Feb; 146(2):344-56. PubMed ID: 7856747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Splicing of the platelet-derived-growth-factor A-chain mRNA in human malignant mesothelioma cell lines and regulation of its expression.
    Langerak AW; Dirks RP; Versnel MA
    Eur J Biochem; 1992 Sep; 208(3):589-96. PubMed ID: 1396665
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of the wt1 Wilms' tumor gene by normal and malignant human melanocytes.
    Rodeck U; Bossler A; Kari C; Humphreys CW; Györfi T; Maurer J; Thiel E; Menssen HD
    Int J Cancer; 1994 Oct; 59(1):78-82. PubMed ID: 7927908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA expression of the WT1 gene in Wilms' tumors in relation to histology.
    Miwa H; Tomlinson GE; Timmons CF; Huff V; Cohn SL; Strong LC; Saunders GF
    J Natl Cancer Inst; 1992 Feb; 84(3):181-7. PubMed ID: 1311774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WT1 induces expression of insulin-like growth factor 2 in Wilms' tumor cells.
    Nichols KE; Re GG; Yan YX; Garvin AJ; Haber DA
    Cancer Res; 1995 Oct; 55(20):4540-3. PubMed ID: 7553624
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of differential expression of platelet-derived growth factor alpha- and beta-receptor mRNA in normal and malignant human mesothelial cell lines.
    Langerak AW; van der Linden-van Beurden CA; Versnel MA
    Biochim Biophys Acta; 1996 Feb; 1305(1-2):63-70. PubMed ID: 8605252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A point mutation within exon 5 of the WT1 gene of a sporadic unilateral Wilms' tumor alters gene function.
    Guan LS; Liu JJ; Xu YH; Wang ZY
    Cancer Res; 1998 Sep; 58(18):4180-4. PubMed ID: 9751632
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrarenal Wilms' tumors. A study of their relationship with classical renal Wilms' tumor using expression of WT1 as a molecular marker.
    Roberts DJ; Haber D; Sklar J; Crum CP
    Lab Invest; 1993 May; 68(5):528-36. PubMed ID: 8388523
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor II and WT1 transcript localization in human fetal kidney and Wilms' tumor.
    Yun K; Fidler AE; Eccles MR; Reeve AE
    Cancer Res; 1993 Nov; 53(21):5166-71. PubMed ID: 8221652
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repression of the insulin-like growth factor II gene by the Wilms tumor suppressor WT1.
    Drummond IA; Madden SL; Rohwer-Nutter P; Bell GI; Sukhatme VP; Rauscher FJ
    Science; 1992 Jul; 257(5070):674-8. PubMed ID: 1323141
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Wilms tumour gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma.
    Park S; Schalling M; Bernard A; Maheswaran S; Shipley GC; Roberts D; Fletcher J; Shipman R; Rheinwald J; Demetri G
    Nat Genet; 1993 Aug; 4(4):415-20. PubMed ID: 8401592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentially spliced exon 5 of the Wilms' tumor gene WT1 modifies gene function.
    Hewitt SM; Saunders GF
    Anticancer Res; 1996; 16(2):621-6. PubMed ID: 8687106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. WT1 mutation in malignant mesothelioma and WT1 immunoreactivity in relation to p53 and growth factor receptor expression, cell-type transition, and prognosis.
    Kumar-Singh S; Segers K; Rodeck U; Backhovens H; Bogers J; Weyler J; Van Broeckhoven C; Van Marck E
    J Pathol; 1997 Jan; 181(1):67-74. PubMed ID: 9072005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
    Zaia A; Fraizer GC; Piantanelli L; Saunders GF
    Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms' tumour-suppressor protein isoforms have opposite effects on Igf2 expression in primary embryonic cells, independently of p53 genotype.
    Duarte A; Caricasole A; Graham CF; Ward A
    Br J Cancer; 1998; 77(2):253-9. PubMed ID: 9460996
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Wilms' tumor gene product, WT1, represses transcription of the platelet-derived growth factor A-chain gene.
    Wang ZY; Madden SL; Deuel TF; Rauscher FJ
    J Biol Chem; 1992 Nov; 267(31):21999-2002. PubMed ID: 1429549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of promoters for the mouse insulin-like growth factor II-encoding gene (Igf-2) by products of the Wilms' tumour suppressor gene wt1.
    Ward A; Pooler JA; Miyagawa K; Duarte A; Hastie ND; Caricasole A
    Gene; 1995 Dec; 167(1-2):239-43. PubMed ID: 8566784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transcriptional activation of the syndecan-1 promoter by the Wilms' tumor protein WT1.
    Cook DM; Hinkes MT; Bernfield M; Rauscher FJ
    Oncogene; 1996 Oct; 13(8):1789-99. PubMed ID: 8895526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional properties of WT1.
    Haber DA; Englert C; Maheswaran S
    Med Pediatr Oncol; 1996 Nov; 27(5):453-5. PubMed ID: 8827073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.